1. Home
  2. DNLI vs NSIT Comparison

DNLI vs NSIT Comparison

Compare DNLI & NSIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DNLI
  • NSIT
  • Stock Information
  • Founded
  • DNLI 2013
  • NSIT 1988
  • Country
  • DNLI United States
  • NSIT United States
  • Employees
  • DNLI N/A
  • NSIT N/A
  • Industry
  • DNLI Biotechnology: Biological Products (No Diagnostic Substances)
  • NSIT EDP Services
  • Sector
  • DNLI Health Care
  • NSIT Technology
  • Exchange
  • DNLI Nasdaq
  • NSIT Nasdaq
  • Market Cap
  • DNLI 2.5B
  • NSIT 2.6B
  • IPO Year
  • DNLI 2017
  • NSIT 1995
  • Fundamental
  • Price
  • DNLI $19.09
  • NSIT $85.37
  • Analyst Decision
  • DNLI Strong Buy
  • NSIT Hold
  • Analyst Count
  • DNLI 13
  • NSIT 3
  • Target Price
  • DNLI $32.64
  • NSIT $128.33
  • AVG Volume (30 Days)
  • DNLI 1.4M
  • NSIT 497.6K
  • Earning Date
  • DNLI 11-06-2025
  • NSIT 10-30-2025
  • Dividend Yield
  • DNLI N/A
  • NSIT N/A
  • EPS Growth
  • DNLI N/A
  • NSIT N/A
  • EPS
  • DNLI N/A
  • NSIT 4.21
  • Revenue
  • DNLI N/A
  • NSIT $8,271,548,000.00
  • Revenue This Year
  • DNLI N/A
  • NSIT N/A
  • Revenue Next Year
  • DNLI $94,232.03
  • NSIT $3.42
  • P/E Ratio
  • DNLI N/A
  • NSIT $19.90
  • Revenue Growth
  • DNLI N/A
  • NSIT N/A
  • 52 Week Low
  • DNLI $10.57
  • NSIT $81.59
  • 52 Week High
  • DNLI $26.18
  • NSIT $181.92
  • Technical
  • Relative Strength Index (RSI)
  • DNLI 69.43
  • NSIT 27.53
  • Support Level
  • DNLI $16.85
  • NSIT $81.59
  • Resistance Level
  • DNLI $18.21
  • NSIT $92.82
  • Average True Range (ATR)
  • DNLI 1.17
  • NSIT 3.16
  • MACD
  • DNLI 0.23
  • NSIT -0.03
  • Stochastic Oscillator
  • DNLI 90.65
  • NSIT 29.18

About DNLI Denali Therapeutics Inc.

Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.

About NSIT Insight Enterprises Inc.

Insight Enterprises Inc is a Fortune IT provider engaged in helping businesses of all sizes, large enterprises, governments, schools, and healthcare organizations. The company has three geographic operating segments: North America, EMEA, and APAC. It generates maximum revenue from the North America segment. The company provides digital innovation, cloud/data center transformation, connected workforce, and supply chain optimization solutions and services.

Share on Social Networks: